User profiles for P. Burge
Peter BurgeRAND Europe Verified email at rand.org Cited by 1803 |
Outcomes for COPD pharmacological trials: from lung function to biomarkers
…, PJ Barnes, V Brusasco, PS Burge… - European respiratory …, 2008 - Eur Respiratory Soc
The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …
Sick building syndrome
PS Burge - Occupational and environmental medicine, 2004 - oem.bmj.com
The sick building syndrome (SBS) consists of a group of mucosal, skin, and general symptoms
that are temporally related to working in particular buildings. It is the workers who are …
that are temporally related to working in particular buildings. It is the workers who are …
Evidence based guidelines for the prevention, identification, and management of occupational asthma
…, P Cullinan, AJN Taylor, PS Burge… - Occupational and …, 2005 - oem.bmj.com
Background: Occupational asthma is the most frequently reported work related respiratory
disease in many countries. This work was commissioned by the British Occupational Health …
disease in many countries. This work was commissioned by the British Occupational Health …
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE …
PS Burge, PMA Calverley, PW Jones, S Spencer… - Bmj, 2000 - bmj.com
… fluticasone propionate compared with placebo (P<0.001). Median … (P=0.026). Health status
deteriorated by 3.2 units a year on placebo and 2.0 units a year on fluticasone propionate (P=…
deteriorated by 3.2 units a year on placebo and 2.0 units a year on fluticasone propionate (P=…
Impact of preventing exacerbations on deterioration of health status in COPD
S Spencer, PMA Calverley, PS Burge… - European respiratory …, 2004 - Eur Respiratory Soc
… Frequent exacerbations were independently associated with a worse baseline SGRQ score
(p<0.0001) and a more rapid rate of deterioration in health status (p=0.0003). Exacerbation …
(p<0.0001) and a more rapid rate of deterioration in health status (p=0.0003). Exacerbation …
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
PMA Calverley, PS Burge, S Spencer, JA Anderson… - Thorax, 2003 - thorax.bmj.com
Background: A limited or absent bronchodilator response is used to classify chronic obstructive
pulmonary disease (COPD) and can determine the treatment offered. The reliability of the …
pulmonary disease (COPD) and can determine the treatment offered. The reliability of the …
The sick building syndrome: prevalence studies.
MJ Finnegan, CA Pickering, PS Burge - Br Med J (Clin Res Ed), 1984 - bmj.com
Random samples or the entire workforce in nine offices in which similar clerical work was
being performed were studied using a doctor administered questionnaire that inquired into …
being performed were studied using a doctor administered questionnaire that inquired into …
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease
…, JA Anderson, NR Anthonisen, AS Buist, PS Burge… - Thorax, 2005 - thorax.bmj.com
… the steroid group (53% v 44%; p = 0.008), and mortality is much more likely in those who
withdrew prematurely than in those who remain in the trial (p<0.001). It is therefore likely that, …
withdrew prematurely than in those who remain in the trial (p<0.001). It is therefore likely that, …
Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients
WS Tunnicliffe, PS Burge, JG Ayres - The Lancet, 1994 - Elsevier
Nitrogen dioxide is a common indoor pollutant. In the light of suggestions that outdoor air
pollution can harm people with asthma, we investigated the effect of 1 h exposures to domestic …
pollution can harm people with asthma, we investigated the effect of 1 h exposures to domestic …
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
PW Jones, LR Willits, PS Burge… - European Respiratory …, 2003 - Eur Respiratory Soc
… higher in the moderate‐to‐severe group than in the mild group (47 versus 41, p<0.01),
but the proportion of continued, mixed and exsmokers was the same in the two groups (p>0.05). …
but the proportion of continued, mixed and exsmokers was the same in the two groups (p>0.05). …